The Education and Research Foundation, Inc.
Lynchburg, Virginia, 24501, United States
NCT Number: NCT00781664
The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Lynchburg, Virginia, 24501, United States
Healthy, adult volunteers of either sex will be patched daily on his/her back with multiple strengths of AN2718 in 2 different topical dosage forms and an active comparator over the course of 21 consecutive days. Twenty-four hours after each application, the patches will be removed and the site evaluated using a five-point scale for irritation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Subjects must meet all of the following criteria for inclusion in the study.
Exclusion criteria
AN2718 Cream SF Vehicle, Daily for up to 21 days
AN2718 Cream SF, 0.3%, Daily for up to 21 days
Sodium Lauryl Sulfate, 0.5%, Daily for up to 21 days
Other names: SLS
Time frame: Daily for 21 days
Pfizer
Industry
21-Day Cumulative Irritation Test
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04152226
Bacterial Infections and Mycoses, Dermatomycoses
Santo Domingo, Dominican Republic
View Trial DetailsNCT00233493
Bacterial Infections and Mycoses, Dermatomycoses
Cleveland, Ohio, United States
View Trial DetailsNCT05363449
Bacterial Infections and Mycoses, Dermatitis
San Diego, California, United States
View Trial DetailsNCT03129321
Bacterial Infections and Mycoses, Dermatomycoses
View Trial Details